Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
CME Activity
Neurology: Volume 77, Number 22, November 29, 2011
Faculty
Yusuf A. Rajabally, MD, FRCP
Department of Neurology
University Hospitals of Leicester
Leicester, UK
Jean Martey, BSc
Department of Neurology
University Hospitals of Leicester
Leicester, UK
E. Matthews, MRCP
MRC Centre for Neuromuscular Disease
UCL Institute of Neurology
London, UK
S. Portaro, MD
MRC Centre for Neuromuscular Disease
UCL Institute of Neurology
London, UK
Department of Neurosciences
Psychiatry and Anaesthesiology
University of Messina
AOU Policlinico “G. Martino”
Messina, Italy
Q. Ke, MD
Department of Neurology
The First Affiliated Hospital of College of Medicine
Zhejiang University
Hangzhou, China
Department of Neurology
University of Rochester
Rochester, NY
R. Sud, PhD
Neurogenetics Unit
National Hospital for Neurology and Neurosurgery
London, UK
A. Haworth, MSc
Neurogenetics Unit
National Hospital for Neurology and Neurosurgery
London, UK
M.B. Davis, PhD
Neurogenetics Unit
National Hospital for Neurology and Neurosurgery
London, UK
R.C. Griggs, MD
Department of Neurology
University of Rochester
Rochester, NY
M.G. Hanna, FRCP
MRC Centre for Neuromuscular Disease
UCL Institute of Neurology
London, UK
Accredited by
American Academy of Neurology
Course Description
Upon completion of the article by Rajabally and Martey, the participant should be able to:
• State how much more likely neuropathy was found in patients with Parkinson disease (PD) as compared to patients with other neurologic conditions in this study
• Discuss the role of vitamin B12 deficiency in causing neuropathy in PD patients
• Discuss clinical factors which may be related to the development of neuropathy in PD patients
Upon completion of the article by Matthews et al, the participant should be able to:
• State the approximate percentage of cases of hypokalemic periodic paralysis (hypoPP) caused by CACNA1S or SCN4A mutations
• Describe the effect of genotype on the probability of response to acetazolamide in patients with hypoPP
• Discuss possible pathophysiological mechanisms underlying different known mutations
Activity Details
| Credit Types: | CME |
| Credit Amount: | 1.5 Credits |
| Release Date: | 2011-Nov-29 |
| Expiration Date: | 2012-Nov-29 |
| Registration Required: | Yes |
| Cost: | $624/yr |
Search
Suggest a CME Activity
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
OpenCME for Publishers
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.
